InsiderTrades.com logo

BLSM Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $5,181,900.00
Insider Selling (Last 12 Months): $0.00

BlossomHill Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at BlossomHill Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BlossomHill Therapeutics Share Price & Price History

Current Price: $15.99
Price Change: ▼ Price Decrease of -0.01 (-0.06%)
As of 08/10/2026 04:00 PM ET

This chart shows the closing price history over time for BLSM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BlossomHill Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2026Bihua ChenDirectorBuy312,500$16.00$5,000,000.003,614,034View SEC Filing Icon  
8/10/2026Jason A KeyesCFOBuy700$16.00$11,200.00700View SEC Filing Icon  
8/10/2026John P SchmidDirectorBuy6,000$16.00$96,000.006,000View SEC Filing Icon  
8/10/2026Vincent Paul LiptakGeneral CounselBuy2,200$16.00$35,200.00111,412View SEC Filing Icon  
8/7/2026Vincent Paul LiptakGeneral CounselBuy2,500$15.80$39,500.00109,212View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BlossomHill Therapeutics (NASDAQ:BLSM)

Read More on BlossomHill Therapeutics

Today's Range

Now: $15.99
Low: $15.97
High: $17.25

50 Day Range

MA: N/A

52 Week Range

Now: $15.99
Low: $15.25
High: $17.25

Volume

417,968 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of BlossomHill Therapeutics?

BlossomHill Therapeutics' top insider investors include:
  1. Bihua Chen (Director)
  2. Vincent Paul Liptak (General Counsel)
  3. John P Schmid (Director)
  4. Jason A Keyes (CFO)
Learn More about top insider investors at BlossomHill Therapeutics.